Skip to main content
War in Gaza:: find out how we're responding
Learn more
7467 Results
 
msf-placeholder
DNDi

New Body Set to Fight Killer Diseases West Ignores

Diseases that kill millions of poor people every year are ignored by Western firms because drugs to combat them make no money, a new research body said as it was launched on Thursday. Project Update - 3 Jul 2003
 
msf-placeholder
Liberia

MSF teams fight cholera and malnutrition in Monrovia IDP camps despite ongoing fighting

Clinics are being opened and camps reached in efforts to stem the spread of cholera, malnutrition, malaria and other illnesses suffered by the displaced citizens in the Liberian capital. Project Update - 3 Jul 2003
 
msf-placeholder
Humanitarian challenges

Charity targets 'forgotten' diseases

Working in conjunction with global research bodies and public health authorities, the charity will spend $250 million over the next 12 years to try to come up with seven new drugs. Project Update - 3 Jul 2003
 
msf-placeholder
DNDi

DNDi diseases focus

DNDi plans to spend around US$250 million over 12 years to develop 6-7 drugs and several drugs in the pipeline to combat sleeping sickness, leishmaniasis and Chagas disease - three killer diseases that threaten a combined 350 million people every year.

Read about these diseases below.
Project Update - 3 Jul 2003
 
msf-placeholder
DNDi

Raiding the medicine cabinet

Reinventing the economics of the drug industry presents a different challenge for MSF. Can MSF and its partners really succeed where the pharmaceutical giants, and their multi-billion-dollar budgets, have failed? Yes, claims Bernard Pecoul, who heads MSF's Access to Essential Medicines campaign. "It's an alternative model based on user needs and equitable access rather than profit," he says. Project Update - 3 Jul 2003
 
msf-placeholder
DNDi

DNDi launch: Best science for the most neglected

New not-for-profit drug research organisation born, DNDI will be the first not-for-profit organisation to exclusively focus on the world's most neglected diseases. Moving away from the traditional Public Private Partnership structure, it intends to take drug development out of the marketplace by encouraging the public sector to take more responsibility for health. Press Release - 3 Jul 2003
 
msf-placeholder
Kala azar

Drugs for neglected diseases

The Drugs for Neglected Diseases Initiative comes amid accusations that the west has ignored the plight of poor patients by either minimising funding or failing to do research on new drugs for diseases that affect them. Project Update - 1 Jul 2003
 
msf-placeholder
United States of America

Damp spirits among G8 fresh pledges

An MSF representative described how the rewritten agenda was defended at the summit by the USA and Germany largely to reflect the interests of their pharmaceutical industries. Project Update - 1 Jul 2003
 
msf-placeholder
Ethiopia

Nutritional situation in Ethiopia deteriorating

MSF has started a nutritional intervention in Ziway area south of the capital Addis Abeba. The Therapeutic Feeding Centre there cannot handle the influx of severely malnourished children and the situation is alarming. Project Update - 1 Jul 2003
 
msf-placeholder
Sierra Leone

New MSF health facility for Liberian refugees

MSF started to build the facility in January due to concerns that refugees were not receiving adequate care through the existing local health structures. Project Update - 27 Jun 2003
Cholera intervention in South Kivu
Médecins Sans Frontières (MSF)

Independent medical humanitarian assistance

We provide medical assistance to people affected by conflict, epidemics, disasters, or exclusion from healthcare. Our teams are made up of tens of thousands of health professionals, logistic and administrative staff - most of them hired locally. Our actions are guided by medical ethics and the principles of independence and impartiality. We are a non-profit, self-governed, member-based organisation.

Learn more